The American College of chest physicians meeting two ofoxandrolone (oxandrolone) report aroused great concern from people, oxandrolone is anabolic steroid drugs for oral administration, increased body weight and restore muscle functionin metabolic diseases for. In acute burn patients requiring mechanical ventilation treatment (burn area accounts for 22 of the total area of the body: 27%) were randomized, placebo controlled trial of oxandrolone. Test the patient to take two times a dayoxandrolone, each 10mg, for 21 to 28 days. Results compared with the placebo group, visceral protein storage test groups wereincreased significantly, and have not found adverse reactions andabnormal liver function serious. The researchers think that need to be studied deeply to determine higher doses of oxandrolonewhether can accelerate recovery of critical burn patientanabolism. Oxandrolone also has the auxiliary treatment of chronic obstructive pulmonary disease (COPD) and unintendedweight loss (IML) potential. In a multicenter, double-blind trial, with both COPD and IML patients were randomized to receive placebo or oxandrolone treatment, daily 10 or 20mg, for 4 months. The preliminary results show that oxandrolone can improve the nutritional status of patients, increased patient body weight andlean body weight, its effect is dose related. It has good toleranceto the drug, but in some cases caused elevated liver enzyme levels, therefore discontinued therapy for these patients.
More about:Oxandrolone sales
From:Hormonehome
No comments:
Post a Comment